1. Alderson NL, Maldonado EN, Kern MJ, Bhat NR & Hama H, 2006, FA2H-dependent fatty acid 2-hydroxylation in postnatal mouse brain, J Lipid Res., 47:2772–2780.
2. Arthur A Spector, 1999, Essentiality of Fatty Acids from Lipids, Vol. 34.
3. Bebo BF Jr, Zelinka-Vincent E, Adamus G, Amundson D, Vandenbark AA & Offner H, 1998, Gonadal hormones influence the immune response to PLP 139-151 and the clinical course of relapsing experimental autoimmune encephalomyelitis, J Neuroimmunol., 15;84(2):122-30.
4. Beckman M, 2004, Neuroscience, Crime, culpability, and the adolescent brain, Science, 30; 305(5684):596-9.
5. Bennett El, Diamond Mc, Krech D & Rosenzweig MR, 1964, Chemical and anatomical plasticity brain, Science, Oct 30; 146(3644):610-9.
6. Casey BJ, Giedd JN & Thomas KM, 2000, Structural and functional brain development and its relation to cognitive development, Biol Psychol., Oct; 54(1-3):241-57
7. Dalal M, Kim S & Voskuhl RR, 1997, Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response, J Immunol., 1;159(1):3-6.
8. Duncan AJ & Heales SJ, 2005, Nitric oxide and neurological disorders, Mol Aspects Med., 26(1-2):67-96. Review
9. Fernando Gomez-Pinilla, 2008, Brain foods: the effects of nutrients on brain function, Nat Rev Neurosci. ; 9(7): 568–578.
10. Giedd JN, 2004, Structural magnetic resonance imaging of the adolescent brain, Ann N Y Acad Sci.; 1021:77-85.
11. Gran B, Hemmer B & Martin R, 1999, Molecular mimicry and multiple sclerosis--a possible role for degenerate T cell recognition in the induction of, autoimmune responses, J Neural Transm Suppl. ;55:19-31.
12. Iuvone T, Esposito G, De Filippis D, Scuderi C & Steardo L, 2009, Cannabidiol: a promising drug for neurodegenerative disorders?, CNS Neurosci Ther., Winter;15 (1):65-75.
13. Lampl C & Yazdi K, 2002, Central pontine myelinolysis, Eur. Neurol., 47 (1): 3–10.
14. Lukiw WJ, Cui JG, Marcheselli VL, Bodker M, Botkjaer A, Gotlinger K, Serhan CN & Bazan NG, 2005, A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease, J Clin Invest., 115 (10): 2774–83.
15. Martin PR, Singleton CK & Hiller–Sturmhöfel SH, 2003, The role of thiamine in alcoholic brain disease, Alcohol Research & Health 27(2):134–142.
16. McNamara RK, Hahn CG & Jandacek R, 2007, Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder, Biol. Psychiatry 62 (1): 17–24.
17. Morgan MY, Alcohol and nutrition, British Medical Bulletins, 38:21–29, 1982.
18. Paus T, Zijdenbos A, Worsley K, Collins DL, Blumenthal J, Giedd JN, Rapoport JL & Evans AC, 1999, Structural maturation of neural pathways in children and adolescents: in vivo study. Science., 283(5409):1908-11.
19. Pozzilli C, Falaschi P, Mainero C, Martocchia A, D'Urso R, Proietti A, Frontoni M, Bastianello S & Filippi M, 1999, MRI in multiple sclerosis during the menstrual cycle: relationship with sex hormone patterns, Neurology, 53(3):622-4.
20. Schmithorst VJ, Wilke M, Dardzinski BJ & Holland SK, 2005, Cognitive functions correlate with white matter architecture in a normal pediatric population: a diffusion tensor MRI study, Hum Brain Mapp., 26(2):139-47.
21. Serhan CN, Gotlinger K, Hong S & Arita M, 2004, Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis Prostaglandins Other Lipid, Mediat. 73 (3–4): 155–72.
22. Soldan SS, Alvarez Retuerto AI, Sicotte NL & Voskuhl RR, 2003, Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol, J Immunol., 1;171(11):6267-74.
23. Victor M, Davis RD, & Collins GH, 1989, The Wernicke–Korsakoff Syndrome and Related Neurologic Disorders Due to Alcoholism and Malnutrition, Philadelphia: F.A. Davis.
24. Yurgelun-Todd DA, Killgore WD & Young AD, 2002, Sex differences in cerebral tissue volume and cognitive performance during adolescence, Psychol Rep., 91(3 Pt 1):743-57